By
Trending Posts
Is the NHS’s New AI Warning System About…
Key Takeaways AI-Powered Safety OverhaulThe NHS announced it will become the first healthcare system worldwide to deploy an…
How Is LogicFlo AI’s $2.7M Seed Round Fueling…
Key Takeaways Transforming Compliance-Driven Workflows With AI AgentsLogicFlo AI, founded by Udith Vaidyanathan and Arun Ramakrishnan, is reinventing…
How Is XtalPi’s Expanded Collaboration With Pfizer Set…
Key Takeaways Empowering Next-Gen AI Platforms for Predictive Drug DiscoveryXtalPi and Pfizer have extended their strategic partnership to…
Is AI-Engineered HMBD-002 the Next Big Immunotherapy? Hummingbird…
Key Highlights Strategic Global Licensing Deal Hummingbird Bioscience has signed a worldwide licensing agreement with Percheron Therapeutics for…
Can ProFound Therapeutics and Novartis’ $750M AI-Driven Cardiovascular…
Key Highlights AI Meets Proteomics: A New Paradigm in Cardiovascular DiscoveryIn a bold step toward AI-enabled medicine, ProFound…
Is Insilico’s AI-Driven UAE University Alliance the Catalyst…
Key Highlights Academic Meets AI Innovation in UAEInsilico Medicine, a leader in generative AI for drug discovery, has…
How Abridge’s $5.3B AI Surge Is Transforming Clinical…
Key Insights: Andreessen Horowitz Leads $300M Bet on Abridge’s Healthcare AI VisionAndreessen Horowitz (A16z) has doubled down on…
Why Sutter Health’s Strategic AI Partnership with Aidoc…
Key Highlights Strategic Collaboration to Scale Clinical AISutter Health has announced a multi-year strategic partnership with Aidoc, embedding…
Is Sanofi’s $632M AI Bet on Formation Bio…
French pharma giant doubles down on AI-native R&D with gusacitinib licensing deal targeting new inflammatory indication Key Takeaways…
Trending Posts
Latest Stories
Can Johnson & Johnson’s Pact with Pacira BioSciences Redefine Early Intervention for Knee Osteoarthritis?
Key Insights Expanding Non-Surgical Pathways Through this agreement, Johnson & Johnson MedTech integrates ZILRETTA® into…
Will BioNTech and Pfizer’s Counterstrike Against GSK Reshape Europe’s Largest mRNA Patent War?
Key Insights GSK’s Offensive Meets Resistance GSK launched a sweeping litigation campaign in 2024, targeting…
Can LB Pharmaceuticals’ $285M IPO Reignite Investor Confidence in Biotech After Months of Silence?
Key Insights IPO Breaks Market Drought LB Pharmaceuticals, a CNS-focused biotech, has defied a months-long…
Is Merck’s £1B Exit Forcing AstraZeneca, Lilly, and Sanofi to Rethink UK’s Life Sciences Future?
Key Insights Merck Triggers Domino Effect with £1B Withdrawal Merck’s decision to abandon its £1-billion…
Gallery
